Literature DB >> 9148001

Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: Doppler sonographic screening in a large family.

E Buscarini1, L Buscarini, C Danesino, M Piantanida, G Civardi, P Quaretti, S Rossi, M Di Stasi, M Silva.   

Abstract

BACKGROUND/AIMS: The prevalence of hepatic vascular malformations in hereditary hemorrhagic telangiectasia has been estimated in the literature on clinical criteria, thus giving unreliable data. In our study the presence of hepatic vascular malformations in hereditary hemorrhagic telangiectasia was evaluated in a large Italian family by using Doppler sonography findings were compared to computed tomography and angiography results. Clinical features were related to the severity of hepatic vascular malformations.
METHODS: Seventy-three relatives were checked for the presence of signs of hereditary hemorrhagic telangiectasia. Abdominal Doppler ultrasonography was performed in all of them. Every subject with a positive Doppler ultrasonography for hepatic vascular malformations underwent abdominal computed tomography and celiac angiography.
RESULTS: Forty family members proved to be affected by hereditary hemorrhagic telangiectasia. Of these, hepatic vascular malformations were evidenced by Doppler ultrasonography in 13 females. Doppler ultrasongraphy demonstrated minimal hepatic vascular abnormalities in three subjects, moderate in three, and severe in seven. Doppler study was diagnostic for arteriovenous shunt with hepatic veins in seven cases and with portal vein in two. Computed tomography failed to demonstrate hepatic vascular malformations in two cases, while angiography confirmed the Doppler sonographic findings in all cases. Cholestasis was present in subjects with moderate and severe hepatic vascular malformations.
CONCLUSIONS: Doppler sonography is the ideal imaging technique to screen hereditary hemorrhagic telangiectasia affected families for hepatic vascular malformations. These malformations do not appear to be age-dependent, but sex-dependent. Cholestasis is the main clinical sign, and it seems to correlate with the severity of hepatic vascular derangement.

Entities:  

Mesh:

Year:  1997        PMID: 9148001     DOI: 10.1016/s0168-8278(97)80017-7

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  18 in total

1.  Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia.

Authors:  T G W Letteboer; J J Mager; R J Snijder; B P C Koeleman; D Lindhout; J K Ploos van Amstel; C J J Westermann
Journal:  J Med Genet       Date:  2005-09-09       Impact factor: 6.318

Review 2.  Hereditary hemorrhagic telangiectasia of the liver complicated by ischemic bile duct necrosis and sepsis: case report and review of the literature.

Authors:  Anastasios Mavrakis; Anthony Demetris; Erin Rubin Ochoa; Mordechai Rabinovitz
Journal:  Dig Dis Sci       Date:  2009-09-16       Impact factor: 3.199

Review 3.  Gastrointestinal Manifestations of Hereditary Hemorrhagic Telangiectasia (HHT): A Systematic Review of the Literature.

Authors:  Samuel B Jackson; Nicholas P Villano; Jihane N Benhammou; Michael Lewis; Joseph R Pisegna; David Padua
Journal:  Dig Dis Sci       Date:  2017-08-23       Impact factor: 3.199

4.  Potential role of modifier genes influencing transforming growth factor-beta1 levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasia.

Authors:  A Bourdeau; M E Faughnan; M L McDonald; A D Paterson; I R Wanless; M Letarte
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

5.  Symptomatic liver involvement in neonatal hereditary hemorrhagic telangiectasia.

Authors:  Suhail Al-Saleh; Philip R John; Michelle Letarte; Marie E Faughnan; Jaques Belik; Felix Ratjen
Journal:  Pediatrics       Date:  2011-05-02       Impact factor: 7.124

6.  Visceral manifestations in hereditary haemorrhagic telangiectasia type 2.

Authors:  S A Abdalla; U W Geisthoff; D Bonneau; H Plauchu; J McDonald; S Kennedy; M E Faughnan; M Letarte
Journal:  J Med Genet       Date:  2003-07       Impact factor: 6.318

7.  Intrahepatic porto-hepatic venous shunts in Rendu-Osler-Weber disease: imaging demonstration.

Authors:  Shunro Matsumoto; Hiromu Mori; Yasunari Yamada; Tomoko Hayashida; Yuzo Hori; Hiro Kiyosue
Journal:  Eur Radiol       Date:  2003-09-20       Impact factor: 5.315

8.  Treatment of high output cardiac failure by flow-adapted hepatic artery banding (FHAB) in patients with hereditary hemorrhagic telangiectasia.

Authors:  A Koscielny; W A Willinek; A Hirner; M Wolff
Journal:  J Gastrointest Surg       Date:  2007-11-20       Impact factor: 3.452

Review 9.  Diagnostic imaging in the study of visceral involvement of hereditary haemorrhagic telangiectasia.

Authors:  M Memeo; A Scardapane; R De Blasi; C Sabbà; A Carella; G Angelelli
Journal:  Radiol Med       Date:  2008-05-13       Impact factor: 3.469

10.  Hereditary Hemorrhagic Telangiectasia Presenting as High Output Cardiac Failure during Pregnancy.

Authors:  Tareq Goussous; Alex Haynes; Katherine Najarian; Marcos Daccarett; Shukri David
Journal:  Cardiol Res Pract       Date:  2009-09-07       Impact factor: 1.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.